Friday, July 18, 2025
HomeTagsOligonucleotide therapies

oligonucleotide therapies

Novartis Acquire Regulus Therapeutics

Novartis announced the successful completion of its acquisition of Regulus Therapeutics, a clinical-stage biopharmaceutical company pioneering oligonucleotide therapies. With this milestone, Regulus becomes an...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics